Trial Profile
Time Since Last Drug Exposure in Pregnancy Determines Adalimumab and Infliximab Levels in Neonates (Era Study)
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Oct 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary)
- Indications Inflammatory bowel diseases
- Focus Pharmacokinetics
- Acronyms ERA
- 15 Oct 2015 New trial record